Isradipine	B:C0071304
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	B:C0000097
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	B:C0007994
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	B:C1512035
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	B:C0027746
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	B:C0288263
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	B:C4022785
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	O
.	O

Isradipine	O
attenuates	O
MPTP	O
-	O
induced	O
dopamine	O
neuron	I:C1512035
degeneration	O
by	O
inhibiting	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
of	O
mice	B:C0025929
.	O

The	O
aim	O
of	O
this	O
study	B:C0008972
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	B:C0288263
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	B:C0288263
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	B:C0000097
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	B:C0007994
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	B:C1512035
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	B:C0027746
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	B:C4022785
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	B:C0038590
nigra	I:C0038590
)	O
of	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
effects	O
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
(	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
)	O
on	O
MPTP	O
-	O
induced	O
dopamine	O
(	I:C1512035
DA	I:C1512035
)	I:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
substantia	I:C4022785
nigra	I:C4022785
(	O
substantia	O
nigra	I:C0038590
)	O
of	O
mice	B:C0025929
.	O

By	O
real	B:C1709846
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	B:C0949466
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	B:C1171362
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	B:C1742148
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	B:C1451807
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	B:C0038590
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	B:C0003064
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	B:C0332293
with	I:C0332293
MPTP	O
.	O

By	O
real	O
-	I:C1709846
time	I:C1709846
PCR	I:C1709846
and	O
western	O
blots	I:C0949466
,	O
we	O
first	O
quatified	O
expressions	O
of	O
L	O
-	I:C1742148
type	I:C1742148
Cav1.2	I:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
experimental	O
mice	I:C0003064
treated	O
with	I:C0332293
MPTP	B:C0000097
.	O

We	O
found	O
that	O
the	O
expressions	B:C1171362
of	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
markedly	O
increased	O
after	O
MPTP	O
treatment	O
for	O
2	O
and	O
3	O
weeks	O
.	O

We	O
found	O
that	O
the	O
expressions	O
of	O
Cav1.2	B:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
markedly	O
increased	O
after	O
MPTP	O
treatment	O
for	O
2	O
and	O
3	O
weeks	O
.	O

We	O
found	O
that	O
the	O
expressions	O
of	O
Cav1.2	O
and	O
Cav1.3	B:C1451807
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
markedly	O
increased	O
after	O
MPTP	O
treatment	O
for	O
2	O
and	O
3	O
weeks	O
.	O

We	O
found	O
that	O
the	O
expressions	O
of	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
markedly	O
increased	O
after	O
MPTP	B:C0000097
treatment	O
for	O
2	O
and	O
3	O
weeks	O
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	B:C0071304
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	B:C0288263
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	B:C0243076
,	O
on	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	B:C0000097
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	B:C0007994
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	O
DA	B:C1512035
neuron	I:C1512035
degeneration	O
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	B:C0027746
and	O
iron	O
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Secondly	O
,	O
we	O
observed	O
the	O
effects	O
of	O
isradipine	O
,	O
a	O
LTCC	O
antagonist	O
,	O
on	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
degeneration	O
and	O
iron	B:C4022785
accumulation	I:C4022785
in	I:C4022785
the	I:C4022785
SN	I:C4022785
.	O

Our	O
results	O
showed	O
that	O
isradipine	B:C0071304
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	B:C0000097
-	O
induced	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	B:C0007994
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	O
Cav1.2	B:C1742148
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	O
Cav1.2	O
and	O
Cav1.3	B:C1451807
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	O
nigra	I:C0038590
.	O

Our	O
results	O
showed	O
that	O
isradipine	O
treatment	O
prevented	O
against	O
MPTP	O
-	O
induced	O
Cav1.2	O
and	O
Cav1.3	O
calcium	I:C1451807
channel	I:C1451807
α1	I:C1451807
subunits	I:C1451807
up	O
-	I:C0041904
regulation	I:C0041904
in	O
the	O
substantia	B:C0038590
nigra	I:C0038590
.	O

We	O
also	O
found	O
that	O
isradipine	B:C0071304
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	B:C0000097
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	B:C0007994
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	B:C1512035
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	B:C0038590
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	B:C1283255
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	B:C0201989
content	I:C0201989
in	O
the	O
striatum	O
.	O

We	O
also	O
found	O
that	O
isradipine	O
prevented	O
against	O
MPTP	O
-	O
induced	O
DA	O
neuron	I:C1512035
depletion	O
in	O
the	O
substantia	O
nigra	I:C0038590
and	O
partly	O
restored	O
the	O
DA	O
content	I:C0201989
in	O
the	O
striatum	B:C0010097
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	B:C0071304
inhibited	O
the	O
increase	O
of	O
iron	O
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
the	O
MPTP	O
-	O
treated	O
mice	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	O
inhibited	O
the	O
increase	O
of	O
iron	B:C2825141
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
the	O
MPTP	O
-	O
treated	O
mice	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	O
inhibited	O
the	O
increase	O
of	O
iron	O
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	B:C0038590
nigra	I:C0038590
of	O
the	O
MPTP	O
-	O
treated	O
mice	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	O
inhibited	O
the	O
increase	O
of	O
iron	O
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
the	O
MPTP	B:C0000097
-	O
treated	O
mice	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	O
inhibited	O
the	O
increase	O
of	O
iron	O
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
the	O
MPTP	O
-	O
treated	B:C0087111
mice	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
isradipine	O
inhibited	O
the	O
increase	O
of	O
iron	O
positive	I:C2825141
cells	I:C2825141
in	O
the	O
substantia	O
nigra	I:C0038590
of	O
the	O
MPTP	O
-	O
treated	O
mice	B:C0025929
.	O

Finally	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
isradipine	B:C0071304
on	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
in	O
the	O
dopaminergic	O
MES23.5	O
cell	I:C0027819
line	I:C0027819
.	O

Finally	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
isradipine	O
on	O
cellular	B:C4022785
iron	I:C4022785
accumulation	I:C4022785
in	O
the	O
dopaminergic	O
MES23.5	O
cell	I:C0027819
line	I:C0027819
.	O

Finally	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
isradipine	O
on	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
in	O
the	O
dopaminergic	B:C1512035
MES23.5	O
cell	I:C0027819
line	I:C0027819
.	O

Finally	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
isradipine	O
on	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
in	O
the	O
dopaminergic	O
MES23.5	B:C0027819
cell	I:C0027819
line	I:C0027819
.	O

Our	O
studies	B:C0008972
showed	O
that	O
MPP	O
+	I:C0000097
treatment	O
accelerated	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Our	O
studies	O
showed	O
that	O
MPP	B:C0000097
+	I:C0000097
treatment	O
accelerated	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Our	O
studies	O
showed	O
that	O
MPP	O
+	I:C0000097
treatment	O
accelerated	O
iron	B:C3548550
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Our	O
studies	O
showed	O
that	O
MPP	O
+	I:C0000097
treatment	O
accelerated	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	B:C0027819
cells	I:C0027819
.	O

Treatment	B:C0087111
with	O
Bayk8644	O
further	O
aggravated	O
iron	O
accumulation	I:C4022785
.	O

Treatment	O
with	O
Bayk8644	B:C0004855
further	O
aggravated	O
iron	O
accumulation	I:C4022785
.	O

Treatment	O
with	O
Bayk8644	O
further	O
aggravated	O
iron	B:C4022785
accumulation	I:C4022785
.	O

Treatment	B:C0087111
with	O
isradipine	O
prevented	O
against	O
MPP	O
+	I:C0000097
-	O
induced	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Treatment	O
with	O
isradipine	B:C0071304
prevented	O
against	O
MPP	O
+	I:C0000097
-	O
induced	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Treatment	O
with	O
isradipine	O
prevented	O
against	O
MPP	B:C0000097
+	I:C0000097
-	O
induced	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Treatment	O
with	O
isradipine	O
prevented	O
against	O
MPP	O
+	I:C0000097
-	O
induced	B:C0007994
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Treatment	O
with	O
isradipine	O
prevented	O
against	O
MPP	O
+	I:C0000097
-	O
induced	O
iron	B:C3548550
influx	I:C3548550
in	O
the	O
MES23.5	O
cells	I:C0027819
.	O

Treatment	O
with	O
isradipine	O
prevented	O
against	O
MPP	O
+	I:C0000097
-	O
induced	O
iron	O
influx	I:C3548550
in	O
the	O
MES23.5	B:C0027819
cells	I:C0027819
.	O

These	O
results	O
suggest	O
that	O
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	B:C0288263
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	B:C1512035
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	B:C0027746
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	B:C0000097
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	B:C0087111
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	B:C0025929
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	B:C0288263
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	B:C3548550
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	B:C1512035
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	B:C0071304
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	B:C4022785
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	O
.	O

These	O
results	O
suggest	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
be	O
responsible	O
for	O
the	O
DA	O
neuron	I:C1512035
degeneration	O
in	O
the	O
MPTP	O
-	O
treated	O
mice	O
,	O
The	O
L	O
-	I:C0288263
type	I:C0288263
calcium	I:C0288263
channels	I:C0288263
may	O
directly	O
contribute	O
to	O
iron	O
influx	I:C3548550
into	O
DA	O
neurons	I:C1512035
,	O
and	O
isradipine	O
may	O
suppress	O
cellular	O
iron	I:C4022785
accumulation	I:C4022785
and	O
prevents	O
neurodegeneration	B:C0027746
.	O

